Siemens and Akesobio sign automation contract for biopharma park

Siemens signed a commercial contract and technical agreement with Akeso Sano Pharma (Akesobio subsidiary) to provide automation and digitalization solutions for the Akesobio Bay Area Science and Technology Park, which includes a 40,000L stainless steel monoclonal antibody production line.

“Siemens will provide fully integrated automation portfolios including DCS, Batch and MCC, as well as the whole integrated digitalization solution from planning and design to implementation, laying a solid foundation for the future intelligent factory.”w1.siemens.com.cn

• 1 source
• w1.siemens.com.cnPress Releases | News | Siemens ChinaFeb 24, 2022

Summarized from public sources; check the original articles before acting on it.